Health condition
VITT awareness
Vaccine-induced immune thrombotic thrombocytopenia (VITT) was a rare syndrome of clots with low platelets linked to adenoviral-vector COVID-19 vaccines; understanding it remains relevant for anyone who experienced it and for the science of anti-PF4 disorders.
Why trust this guide
- 01
Editorial team
Written by our editorial team from the UK sources listed on each page.
- 02
Sourced from guidance
Checked against current NHS and UK specialist society guidance at the time of review.
- 03
Current for 2026
Reviewed on 2026-09-27 with the next review scheduled for 2027-09-27.
Key facts
The essentials at a glance.
The symptoms to recognise, when to seek help, which specialist to see, and what treatment usually involves.
-
Caused by anti-PF4 antibodies arising after adenoviral-vector vaccination
-
Characterised by unusual-site clots - especially cerebral vein thrombosis - with low platelets
-
Treated with non-heparin anticoagulation and intravenous immunoglobulin
-
Anti-PF4 syndromes can rarely occur outside vaccination, so awareness retains clinical value
Understanding the condition
What it is and what happens next.
What causes it, how it is diagnosed, and the treatment routes available in the UK.
What it is and how it feels
VITT emerged in 2021 as a distinct entity: days after a first adenoviral-vector COVID vaccine dose, a small number of people developed aggressive thrombosis - frequently cerebral venous sinus thrombosis - together with thrombocytopenia, very high D-dimers and antibodies against platelet factor 4, mechanistically echoing heparin-induced thrombocytopenia without any heparin exposure.
Diagnosis and treatment routes
Rapid international collaboration defined diagnosis and treatment - non-heparin anticoagulants plus immunoglobulin - and outcomes improved markedly as recognition spread. With those vaccines no longer in UK use, new cases have essentially ceased, but the episode leaves a legacy: survivors need informed follow-up and documentation, and clinicians now recognise a broader family of spontaneous anti-PF4 disorders that can mimic it. In many parts of the UK, routine NHS referrals for this kind of problem can take months, whereas an initial appointment with a private consultant is typically available within around two weeks.
Seeing a specialist
Who to see, and how quickly you can be seen.
The specialist for this condition is usually a consultant haematologist. Your GP can refer you on the NHS, or you can arrange a private consultation directly.
A quiet reminder
This guide is for information, not medical advice.
Your GP knows your history and can tell you which parts apply to you. If in doubt, see them - and seek urgent care for any of the emergency symptoms described above.
Frequently asked
Common questions about VITT awareness.
Quick, plain-English answers to what people ask us most.
-
What is VITT (vaccine-induced immune thrombotic thrombocytopenia)?
It is a rare condition in which the immune system produces antibodies that activate platelets, causing both blood clots (thrombosis) and a low platelet count, identified as a rare complication of certain adenovirus-vector COVID-19 vaccines.
-
What causes VITT?
It's caused by an unusual immune response in which specific antibodies activate platelets excessively, leading to clot formation while simultaneously using up platelets, causing a paradoxical combination of clotting and low platelet count.
-
What are the symptoms of VITT?
Symptoms depend on where clots form but can include severe headache, abdominal pain, leg swelling or pain, breathlessness, or unusual bruising, typically developing within about four to thirty days after the relevant vaccine.
-
Is VITT dangerous?
Yes, it is a serious condition, particularly because clots can form in unusual locations such as the brain's venous sinuses, but it is very rare, and awareness and prompt recognition have significantly improved outcomes with appropriate treatment.
-
Can VITT be treated?
Yes, specific treatment protocols have been developed, including particular blood thinning medications (avoiding heparin, which can worsen the condition), immunoglobulin therapy, and specialist haematology input, which have significantly improved survival rates.
-
How is VITT diagnosed?
Diagnosis involves blood tests showing low platelet count alongside specific antibody testing, combined with imaging to identify any blood clots, in someone with a relevant recent vaccine history and compatible symptoms.
-
How rare is VITT?
It is very rare, occurring in a small number of cases per million doses of the specific vaccines associated with it, and the specific vaccines linked to this risk are no longer widely used in many countries' current vaccination programmes.
-
VITT vs typical vaccine side effects - what's the difference?
Typical vaccine side effects are mild and self-limiting (soreness, low fever), while VITT is a rare, specific and serious immune reaction causing clotting and low platelets, requiring urgent specific treatment; the distinctive symptom pattern and timing help distinguish it.
-
When should I seek urgent care for possible VITT symptoms, and how quickly?
Seek immediate emergency care for severe headache, leg swelling, breathlessness, or abdominal pain occurring four to thirty days after a relevant vaccine, as prompt specific treatment significantly improves outcomes.